Eurobio Scientific Société anonyme (EPA: ALERS)

ALERS Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	56.2	56.2	61.68	97.13	80.33	50.3
Short-Term Investments	0.12	0.12	0.18	-	-	-
Cash & Short-Term Investments	56.31	56.31	61.86	97.13	80.33	50.3
Cash Growth	-8.97%	-8.97%	-36.31%	20.91%	59.70%	132.95%
Accounts Receivable	51.58	51.58	46.62	30.49	32.47	20.95
Other Receivables	10.99	10.99	12.14	9.12	11.9	4.9
Receivables	62.57	62.57	58.77	39.61	44.37	25.84
Inventory	77.54	77.54	65.4	45.85	37.2	26.26
Other Current Assets	0.84	0.84	1.1	0.29	0.41	0.9
Total Current Assets	197.27	197.27	187.13	182.87	162.31	103.31
Property, Plant & Equipment	57.19	57.19	48.16	34.55	29.35	18.02
Long-Term Investments	7.5	7.5	7.5	7.5	-	-
Goodwill	72.59	72.59	69.94	70.26	69.21	40.1
Other Intangible Assets	12.1	12.1	12.96	12.53	12.53	3.55
Long-Term Deferred Tax Assets	7.29	7.29	2.44	1.03	2.04	1.7
Long-Term Deferred Charges	37.37	37.37	31.99	28.41	22.83	19.96
Other Long-Term Assets	13.44	13.44	11.47	10.06	6.77	6.81
Total Assets	405.25	405.25	372.04	347.62	305.43	193.76
Accounts Payable	17.59	17.59	18.12	13.19	11.95	9.1
Accrued Expenses	20.24	20.24	17.58	15.28	13.74	7.31
Short-Term Debt	0.07	0.07	1.38	1.2	1.19	1.29
Current Portion of Long-Term Debt	13.61	13.61	61.85	10.54	13.86	3.93
Current Portion of Leases	2.8	2.8	2.33	2.43	1.74	1.87
Current Income Taxes Payable	2.97	2.97	0.86	0.88	0.74	0.01
Current Unearned Revenue	3.6	3.6	4.61	4.02	5.59	5.76
Other Current Liabilities	13.23	13.23	13.11	10.4	8.56	5.08
Total Current Liabilities	74.1	74.1	119.85	57.94	57.37	34.34
Long-Term Debt	121.57	121.57	41.44	93.1	67.65	21.55
Long-Term Leases	7.03	7.03	7.18	4.76	3.88	3.45
Long-Term Unearned Revenue	4.56	4.56	4.43	5.01	4.48	3.18
Long-Term Deferred Tax Liabilities	1.85	1.85	2.58	0.87	0.6	0
Other Long-Term Liabilities	0.25	0.25	0.47	1.51	4.74	3.78
Total Liabilities	211.95	211.95	178.61	166.3	141.35	68.81
Common Stock	22.47	22.47	22.47	22.47	22.47	18.43
Additional Paid-In Capital	86.1	86.1	86.1	86.1	86.11	54.56
Retained Earnings	7.13	7.13	11.35	13.86	5.64	8.82
Treasury Stock	-6.74	-6.74	-3.6	-2.6	-2.86	-0.18
Comprensive Income & Other	84.35	84.35	77.12	61.5	52.73	43.31
Shareholders' Equity	193.3	193.3	193.44	181.33	164.09	124.95
Total Liabilities & Equity	405.25	405.25	372.04	347.62	305.43	193.76
Total Debt	145.08	145.08	114.18	112.03	88.31	32.08
Net Cash (Debt)	-88.76	-88.76	-52.32	-14.9	-7.98	18.22
Net Cash Per Share	-3.98	-3.98	-2.35	-0.67	-0.42	1.07
Filing Date Shares Outstanding	22.08	22.08	22.29	22.19	22.2	18.41
Total Common Shares Outstanding	22.08	22.08	22.29	22.21	22.2	18.41
Working Capital	123.17	123.17	67.28	124.93	104.94	68.96
Book Value Per Share	8.75	8.75	8.68	8.17	7.39	6.79
Tangible Book Value	108.61	108.61	110.54	98.53	82.34	81.3
Tangible Book Value Per Share	4.92	4.92	4.96	4.44	3.71	4.42
Land	5.49	5.49	3.83	3.8	1.55	1.55
Buildings	24.1	24.1	13.12	9.6	13.89	7.85
Machinery	31	31	22.42	19.28	18.22	13.28
Construction In Progress	3.91	3.91	9.79	0.5	0.02	0.47

Source: S&P Capital IQ. Standard template. Financial Sources.